DARA BioSciences, Inc. to Present at the 13th Annual Biotech & Specialty Pharmaceuticals Industry Investor Conference of the New York Society of Security Analysts (“NYSSA”)

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), a development-stage biopharmaceutical company, today announced that the Company will present at the New York Society of Security Analysts’ 13th Annual Biotech & Specialty Pharmaceuticals Industry investor conference to be held on December 1 in New York City. The New York Society of Security Analysts (NYSSA) serves 11,000 members and 30,000 Wall Street decision makers.